Safety Monitoring

Quantitative analysis of two impurities in lanthanum carbonate by X-ray powder diffraction

Expand
  • 1. Henan Vocational University of Science and Technology, Zhoukou 466000, China;
    2. Shandong Dyne Marine Organism Pharmaceutical Co., Ltd., Weihai 264300, China;
    3. China Chemical Science Research Institute Co., Ltd., Beijing 102402, China

Received date: 2022-05-18

  Online published: 2024-06-25

Abstract

Objective: To develop a method to determine the content of impurity Ⅰ and impurity Ⅱ in lanthanum carbonate raw materials by X-ray powder diffraction, and provide a simple, convenient and feasible quantitative analysis method for the stability research and quality control of lanthanum carbonate drugs. Methods: Single peak method, the detection sensitivity was improved by optimizing the detection parameters, and the characteristic diffraction peak of impurity I was 2θ=17.8 ° and characteristic diffraction peak of impurity Ⅱ was 2θ=26.1 °. The height of diffraction peak was used as the quantitative parameter, and the linear relationship between the peak height and impurity content was established. The content of impurity I and impurity Ⅱ in lanthanum carbonate API samples were determined by the standard curve method. By optimizing the hybrid method, the repeatability of the method was improved. Results: The heights of characteristic diffraction peaks of impurity Ⅰ and impurity Ⅱ showed a good linear relationship with their content. The detection limits of impurity Ⅰ and impurity Ⅱ were 0.55% and 0.29%, respectively. The linear range of impurity Ⅰ was 0.55%-5.06%, the linear equation was Y=408.77X-103.8, and the correlation coefficient r=0.992 1. The linear range of impurity Ⅱ was 0.29%-5.12%, the linear equation square was Y=816.95X-182.52, and the correlation coefficient r=0.996 0. The accuracy of impurity Ⅰ and impurity Ⅱ were 95.9% and 96.1% respectively, and the RSD of repeatability were 6.8% and 7.1% respectively. The contents of impurity Ⅰ and impuriyt Ⅱ in the three batches of samples were lower than the corresponding detection limit. Conclusion: The quantitative method established in this study is accurate, reliable, fast and simple, and can be used for the quantitative analysis of two impurities in lanthanum carbonate raw materials.

Cite this article

JING Yi-wen, AN Yang, ZHANG Ting-ting, GUO Wei, ZHANG Wei-feng, XIAO Chao-qiang, HE Shu-wang . Quantitative analysis of two impurities in lanthanum carbonate by X-ray powder diffraction[J]. Chinese Journal of Pharmaceutical Analysis, 2023 , 43(4) : 660 -667 . DOI: 10.16155/j.0254-1793.2023.04.15

References

[1] JAN A, ANNE-LISE BM. Lanthanum carbonate-a new phosphate binding drug in advanced renal failure[J].Curr Med Chem, 2018, 25(1): 113
[2] HIROAKI O, MASAFUMI F, HIDEKI H, et al. Effect of treating hyperphosphatemia with lanthanum carbonate vs calcium carbonate on cardiovascular events in patients with chronic kidney disease undergoing hemodialysis: the LANDMARK randomized clinical trial[J].JAMA, 2021, 325(19): 1946
[3] 夏尔国际许可有限公司. 碱式碳酸镧的检定法: 中国, 200780024593.3[P].2009-07-15
Shire International Licensing Co., Ltd. Determination of Basic Lanthanum Carbonate: China, 200780024593.3[P].2009-07-15
[4] 张应. 碳酸镧的制备工艺研究及与碱式碳酸镧的鉴别研究[D].开封: 河南大学, 2012
ZHANG Y. Study on the Preparation of Lanthanum Carbonate and Identification of Basic Lanthanum Carbonate[D].Kaifeng: Henan University, 2012
[5] 马雨璇, 王娜, 李钢. 药用四水碳酸镧及其杂质碱式碳酸镧的定性和定量分析[J].分析仪器, 2021(4): 9
MA YX, WANG N, LI G. Qualitative and quantitative analysis of pharmaceutical lanthanum carbonate tetrahydrate and its impurity lanthanum basic carbonate[J].Anal Instrum, 2021(4): 9
[6] 梁敬魁. 粉末衍射法测定晶体结构: X射线衍射结构晶体学基础[M].北京: 科学出版社, 2011
LIANG JK. Determination of Crystal Structure by Powder Diffraction: Crystallographic Basis of X-ray Diffraction Structure[M].Beijing: Science Press, 2011
[7] 梁敬魁. 粉末衍射法测定晶体结构:X射线衍射在材料科学中的应用[M].北京: 科学出版社, 2011
LIANG JK. Determination of Crystal Structure by Powder Diffraction: application of X-ray diffraction in material science[M].Beijing: Science Press, 2011
[8] 肖燕, 王静康, 尹秋响, 等. 固体药物晶型定量分析方法[J].石油化工, 2015, 44(1): 8
XIAO Y, WANG JK, YIN QX, et al. Quantitative analyzing methods for polymorphism of pharmaceuticals[J].Petrochem Technol, 2015, 44(1): 8
[9] 戚淑叶, 邹文博, 姚尚辰, 等. 注射用头孢噻肟钠晶型一致性评价研究[J].药物分析杂志, 2021, 41(10): 8
QI SY, ZOU WB, YAO SC, et al. Evaluation of crystal form consistency of cefotaxime sodium for injection[J].Chin J Pharm Anal, 2021, 41(10): 8
[10] 中华人民共和国药典2020年版. 四部[S].2020: 55, 457
ChP 2020.Vol Ⅳ[S].2020: 55, 457
[11] ICH. Q2(R1): Validation of Analytical Procedures Text and Methodology[S].2005: 11
[12] 刘红超, 郭常霖. 研究固体微结构的X射线粉末衍射全谱图拟合方法[J].物理学进展, 1996, 16(2):23
LIU HC, GUO CL. X-Ray powder diffraction full-pattern-fitting method studying on the solid microstructure[J].Prog Phys, 1996, 16(2): 23
[13] 曾令民, 杨喜英, 王力珩, 等. X射线衍射里特沃尔德全谱图拟合法测定粉尘中游离的SiO2[J].分析化学, 2008, 36(5): 5
ZENG LM, YANG XY, WANG LH, et al. Determination of weight concentration of free silicon dioxide for dust using X-ray diffraction technique and rietveld refinement method[J].Chin J Anal Chem, 2008, 36(5): 5
[14] 徐婷, 王彦, 朱美兰, 等. 盐酸文拉法辛多晶型X-射线粉末衍射定量分析[J].中国新药杂志, 2017, 26(21): 6
XU T, WANG Y, ZHU ML, et al. Quantitative determination of venlafaxine hydrochloride polymorphs using X-ray powder diffractometry[J].Chin New Drugs J, 2017, 26(21): 6
[15] 黄继武, 李周. 多晶材料X射线衍射―实验原理、方法与应用[M].北京: 冶金工业出版社, 2012: 9
HUANG JW, LI Z. X-ray Diffraction of Polycrystalline Materials-Experimental Principle, Method and Application[M].Beijing: Metallurgical Industry Press, 2012: 9
Outlines

/